Network origin in Antoine Béret first degree
Entity | Entity type | Industry | |
---|---|---|---|
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Antoine Béret via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
IMMUNOTECH LABORATORIES, INC. | Pharmaceuticals: Major | Founder | |
NICOX SA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pierre Fabre SA
Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Undergraduate Degree | |
Rutgers State University of New Jersey | College/University | Masters Business Admin | |
The University of California, San Francisco | College/University | Corporate Officer/Principal | |
Pfizer, Inc. /Angers & Val-de-Reuil Pharmaceutical Operations | Pharmaceuticals: Major | President | |
Université de Technologie de Compiègne | College/University | Doctorate Degree | |
Ecole Polytechnique | College/University | Undergraduate Degree | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin | |
Université des Sciences et Technologies de Lille | College/University | Graduate Degree | |
Université de Franche-Comté | College/University | Undergraduate Degree | |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member | |
Académie des Technologies
Académie des Technologies Academie des Technologies engages in the technology industry. The company was founded in December 2000 and is headquartered in Paris, France. | Corporate Officer/Principal | ||
Bausch & Lomb (Australia) Pty Ltd.
Bausch & Lomb (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Bausch & Lomb Australia Pty Ltd. manufactures and distributes prescription medicines. It offers consumer healthcare, prescription, aesthetic skin and eyecare. The company was founded in 2006 and is headquartered in Chatswood, Australia. | Pharmaceuticals: Major | Corporate Officer/Principal | |
TXCELL | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
Parke-Davis Pharmaceutical Research, Inc. | Corporate Officer/Principal | ||
HRA Pharma Development SARL
HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology HRA Pharma Development SARL develops medicines and products for women's health and endocrinology. It offers emergency contraception, uterine fibroids, regular contraception, intimate health, genital herpes, and Lysosafe service. The company was founded by André Ulmann in 1996 and is headquartered in Châtillon, France. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Sanofi-Synthelabo Canada, Inc. | Corporate Officer/Principal | ||
Boehringer Ingelheim France SASU
Boehringer Ingelheim France SASU Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim France SAS engages in the research, development, marketing, and distribution of pharmaceuticals. The company was founded on October 31, 1986 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Glaxo Wellcome Immobilière de Recherche SA
Glaxo Wellcome Immobilière de Recherche SA Real Estate DevelopmentFinance Glaxo Wellcome Immobilière de Recherche SA provides real estate services. The company was founded in 1992 and is headquartered in Marly-le-Roi, France. | Real Estate Development | Corporate Officer/Principal | |
CANTARGIA AB | Pharmaceuticals: Major | Director/Board Member | |
Université d'Aix-Marseille | College/University | Graduate Degree | |
CIRCIO HOLDING ASA | Biotechnology | Chairman | |
Theralpha | Director/Board Member | ||
Innovative Concepts in Drug Development SAS
Innovative Concepts in Drug Development SAS BiotechnologyHealth Technology Innovative Concepts in Drug Development SAS develops and provides innovative proprietary screening platforms to the pharmaceutical development sector. The company was founded by Natahlie Compagnone in 2007 and is headquartered in Gemenos, France. | Biotechnology | Chief Executive Officer | |
THERANEXUS | Pharmaceuticals: Major | Corporate Officer/Principal | |
Loxbridge Research LLP
Loxbridge Research LLP Financial ConglomeratesFinance Loxbridge Research LLP operates as an investment and project management company. It specializes in startup, early stage, and later stage investments in growth stage companies. The firm supports scientists and focuses on sectors like science, medicine and healthcare technology particularly biotech, med-tech, noval therapeutic, diagnostics, cancer, infectious diseases, neurodegeneration, imaging hardware and software, and enabling devices. The company was founded by Charles Roberts in 2008 and is headquartered in London, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
Agalimmune Ltd.
Agalimmune Ltd. Pharmaceuticals: MajorHealth Technology Part of BioLineRx Ltd., Agalimmune Ltd. is a British company that develops anti-cancer immunotherapy technology. The company is based in London, UK. The company was founded by Charles Campbell Roberts and Graham Griffiths. The CEO is Mike Westby. Agalimmune was acquired by BioLineRx Ltd. on March 23, 2017 for $6.05 million. | Pharmaceuticals: Major | Director/Board Member | |
Resolys Bio, Inc.
Resolys Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Resolys Bio, Inc. operates as a pharmaceutical company. The firm develops OSLO and MCC for the treatment of certain forms of traumatic brain injury and chronic painful tissue disorders. The company is headquartered in Delanson, NY. | Miscellaneous Commercial Services | Director/Board Member | |
INVENTIVA | Biotechnology | Chief Tech/Sci/R&D Officer | |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Cytoseek Ltd.
Cytoseek Ltd. Miscellaneous Commercial ServicesCommercial Services Cytoseek Ltd. provides cell membrane augmentation technology for enhancement of cell therapies for cancer, heart disease, osteoarthritis, and diabetic wound healing. It enables new functionalities to cell therapies including tissue specific targeting and enhanced cell survivability. The company was founded by Adam Willis Perriman on November 22, 2017 and is headquartered in Bristol, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
Pepgen Ltd.
Pepgen Ltd. Packaged SoftwareTechnology Services Pepgen Ltd. engages in research and experimental development on biotechnology. The company was founded on January 25, 2018 and is headquartered in Oxford, the United Kingdom. | Packaged Software | Chairman | |
Treehill Partners, LLC | Corporate Officer/Principal | ||
Imophoron Ltd.
Imophoron Ltd. BiotechnologyHealth Technology Imophoron Ltd. is an American company that specializes in cutting-edge vaccine development. The company's scientific advisory board consists of world-leading experts in vaccine technology and infectious diseases. The company is constantly exploring new and innovative ways to combat infection using the latest techniques from science and technology. More information about the company can be found on their website at www.imophoron.com. The company was founded by Fred Garzoni and Richard Edward Bungay has been the CEO of the company since 2022. | Biotechnology | Chairman | |
Orphan Europe SARL
Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Orphan Europe SARL develops and distributes orphan drugs for the treatment of rare diseases. The firm's products include Normosang, Cystagon, Pedea, Carbaglu, Wilzin, Cystadane. The company was founded by William Gunnarsson in 1990 and is headquartered in Puteaux, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pfizer Holding France SCA
Pfizer Holding France SCA Pharmaceuticals: MajorHealth Technology Pfizer Holding France SCA manufactures and supplies pharmaceutical products. The company was founded in 1961 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistics
International
France | 26 |
United Kingdom | 8 |
United States | 6 |
Australia | 2 |
Canada | 2 |
Sectoral
Health Technology | 21 |
Consumer Services | 11 |
Commercial Services | 5 |
Finance | 3 |
Technology Services | 2 |
Operational
Corporate Officer/Principal | 23 |
Director/Board Member | 10 |
Chief Tech/Sci/R&D Officer | 7 |
Chief Executive Officer | 5 |
Chairman | 4 |
Most connected contacts
Insiders | |
---|---|
Damian Marron | 21 |
Jean-Louis Abitbol | 8 |
Patrick Berna | 6 |
Michel Delaage | 5 |
Nathalie Compagnone | 5 |
Julien Veys | 4 |
Rebecca Pruss | 2 |
- Stock Market
- Insiders
- Antoine Béret
- Company connections